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Background: Cardiac death is one of the leading causes of death and sudden cardiac
death (SCD) is estimated to cause approximately 50% of cardiac deaths. Men have a
higher cardiac mortality than women. Consequently, the mechanisms and risk markers
of cardiac mortality are not as well defined in women as they are in men.
Aim: The aim of the study was to assess the prognostic value and possible gender
differences of SCD risk markers of standard 12-lead electrocardiogram in three large
general population samples.
Methods: The standard 12-lead electrocardiographic (ECG) markers were analyzed
from three different Finnish general population samples including total of 20,310 subjects
(49.9% women, mean age 44.8 ± 8.7 years). The primary endpoint was cardiac death,
and SCD and all-cause mortality were secondary endpoints. The interaction effect
between women and men was assessed for each ECG variable.
Results: During the follow-up (7.7 ± 1.2 years), a total of 883 deaths occurred (24.5%
women, p < 0.001). There were 296 cardiac deaths (13.9% women, p < 0.001) and
149 SCDs (14.8% women, p < 0.001). Among those who had died due to cardiac
cause, women had more often a normal electrocardiogram compared to men (39.0 vs.
27.5%, p = 0.132). After adjustments with common cardiovascular risk factors and the
population sample, the following ECG variables predicted the primary endpoint in men:
left ventricular hypertrophy (LVH) with strain pattern (p < 0.001), QRS duration > 110 ms
(p < 0.001), inferior or lateral T-wave inversion (p < 0.001) and inferolateral early
repolarization (p = 0.033). In women none of the variables remained significant predictors
of cardiac death in multivariable analysis, but LVH, QTc ≥ 490 ms and T-wave inversions
predicted SCD (p < 0.047 and 0.033, respectively). In the interaction analysis, LVH
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(HR: 2.4; 95% CI: 1.2–4.9; p = 0.014) was stronger predictor of primary endpoint in
women than in men.
Conclusion: Several standard ECG variables provide independent information on the
risk of cardiac mortality in men but not in women. LVH and T-wave inversions predict
SCD also in women.
Keywords: gender differences, ECG, sudden cardiac death, cardiac death, left ventricular hypertrophy, prolonged
QRS, T wave inversion
INTRODUCTION
Cardiovascular disease (CVD) remains the leading cause of death
worldwide both in women and men, despite of the overall
reduction in CVD mortality (Naghavi et al., 2015; Maffei et al.,
2019). The death rates for CVD have declined 22% from 2005
to 2015 (Benjamin et al., 2018), but they seem now to be
again increasing among US women, probably due to obesity
epidemic (Mosca et al., 2011). Even though the first female-
specific recommendation for prevention of CVD was published
by American Heart Association in 1995 (Mosca et al., 1999), the
erroneous perception that women are protected against CVD
is still strong (Sciomer et al., 2018). Traditional Framingham
risk factors for CVD have shown to increase the risk of cardiac
mortality in both genders (Greenland et al., 2003) even though
the impact of classical risk factors for CVD are likely to also
differ among men and women (Maffei et al., 2019). In addition,
there are many risk factors unique for women associating to
reproductive capability and pregnancy, and the development
of CVD in women may correlate with some specific events
occurring in their reproductive history (Maffei et al., 2019).
Supplementing the traditional risk assessment with
electrocardiographic (ECG) risk markers drawn from standard
12-lead electrocardiogram might assist in detecting subclinical
changes in cardiac structure and function in previously
asymptomatic subjects. These subjects with elevated risk
for CVD could then be referred to risk reduction therapies
(O’Malley and Redberg, 2012). In previous literature, ST-
segment depression, T-wave inversion, ECG signs of left
ventricular hypertrophy (LVH) including strain and premature
ventricular contractions have been associated with 2–10-fold risk
for coronary artery disease (CAD) events (Chou et al., 2011) and
combined cardiovascular events (Jørgensen et al., 2014) among
asymptomatic subjects. In addition, recent studies have shown
that prolonged QRS duration (Aro et al., 2011), certain patterns
of early repolarization (Tikkanen et al., 2009; Junttila et al., 2014)
and fragmented QRS complex predict cardiac mortality (Terho
et al., 2014). Studies evaluating screening for the risk of cardiac
mortality using resting electrocardiogram, focusing especially on
gender differences in general populations, are sparse (Holkeri
et al., 2020). In the future the lack of awareness of the high CVD
risk among certain subgroups of women must be overcome,
Abbreviations: BMI, body mass index; CAD, coronary artery disease; CI,
confidence interval; CVD, cardiovascular disease; ECG, electrocardiographic; ER,
early repolarization; fQRS, fragmented QRS complex; HR, hazard ratio; LVH, left
ventricular hypertrophy; SCD, sudden cardiac death; SD, standard deviation.
and better sex-specific risk assessment tools for cardiovascular
mortality needs to be developed. The aim of the current study
was to assess the prognostic value of ECG risk markers for
cardiac mortality but also for SCD and all-cause mortality in
three large general population samples and conceive possible
gender differences in the prognostic value of these markers.
MATERIALS AND METHODS
Patient Populations
Standard 12-lead ECGs were analyzed from 20,310 participants
(49.9% women, mean age 44.8± 8.7 years) of the Coronary Heart
Disease Study of the Finnish Mobile Clinic Health Examination
Survey (N = 10,807), the Mini-Finland Health Survey (N = 5,143)
and the Health 2000 Health Examination Survey (N = 4,360).
All three studies are general population-based surveys of middle-
aged subjects including the approximately similar number of
women and men from different geographical areas in Finland.
The studies were conducted in different eras by Social Insurance
Institution and National Institution for Health and Welfare.
Flowchart in Figure 1 represents the final study population.
The Finnish Mobile Clinic Health Examination Survey
(1966–1972)
The Coronary Heart Disease Study of the Finnish Mobile Clinic
Health Examination Survey consists total of 10,957 subjects
aged 30–61 years. The study was carried out between 1966
and 1972 in 4 different geographical areas in Finland. The
details of the study population have been described previously
(Reunanen et al., 1983). The study subjects underwent recording
of standard 12-lead resting electrocardiogram, measurement of
blood pressure and body mass index (BMI), and completed a
questionnaire regarding their health behavior, known diseases
and medications. After excluding 53 subjects with unreadable
electrocardiogram and subjects with bundle branch blocks,
10,807 subjects were included in the present study (47.8% female,
mean age 44.0± 8.5 years).
The Mini-Finland Health Survey (1978–1980)
The Mini-Finland Health Survey was conducted between 1978
and 1980, and the primary study population of 8,000 subjects
aged≥ 30 years and was representative of the Finnish population
at the time. Out of these subjects, 7,217 participated in similar
health examinations and measurements as in Mobile Clinic Study
above. The detailed descriptions of the study protocol have been
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FIGURE 1 | A flowchart of the patient populations.
published elsewhere (Knekt et al., 2017). In the current study,
subjects older than 61 years were excluded to standardize the
study samples. After exclusion, a total of 5,143 subjects (52.2%
female, mean age 44.6 ± 9.2 years) remained in the final study
population sample.
The Health 2000 Survey (2000–2001)
The Health 2000 Health Examination Survey was carried out
between 2000 and 2001. The primary study population contained
a representative sample of 8,028 adults between ages 30 and 80.
The baseline examinations were conducted on 6,345 subjects
and after excluding unreadable electrocardiograms 6,305 subjects
remained (54.6% female, mean age 51.5± 12.8 years). The details
of study population have been described previously (Heistaro,
2020). In the current study, subjects over 61 years old were
excluded to standardize the study samples. After exclusions, a
total of 4,360 subjects (52.3% female, mean age 45.5 ± 8.4 years)
remained in the final study population sample.
Electrocardiography
The standard resting 12-lead electrocardiograms were recorded
at paper speed of 50 mm/s and calibration of 10 mm/mV at
study baseline. QRS duration and QT interval were measured
from leads II or V5. QRS duration was considered prolonged
if it was ≥ 110 ms. Heart rate correction for the QT interval
was performed with Bazett’s formula. The presence of early
repolarization ≥ 0.1 mV with horizontal or descending ST
segment and fragmented QRS were assessed as described
previously (Tikkanen et al., 2009; Terho et al., 2014). Early
repolarization was classified inferolateral if there were≥ 2 slurred
or notched J-point elevations ≥ 0.1 mV in inferior (II, III,
aVF) or lateral (I, aVL, V4–V6) leads. ST segment was classified
as horizontal or descending if it was under 0.1 mV 100 ms
after the end of the QRS complex. Fragmented QRS complexes
were classified by coronary artery regions as anterior (V1–V3),
inferior or lateral if there were ≥ 2 fragmented QRS complexes
within the region. Similarly, inferolateral T-wave inversions were
classified by coronary artery regions as inferior or lateral if T-wave
amplitude was < −0.1 mV in ≥ 2 contiguous leads in the
same region. The Sokolow-Lyon criteria was used for grading
electrocardiographic LVH, i.e., if the sum of S wave amplitude
in V1 and R wave amplitude in V5/V6 (whichever larger)
was≥35 mm, electrocardiogram was graded as positive for LVH.
By LVH with repolarization abnormalities we refer to ECG sign
of LVH observed with inferior or lateral T-wave inversions. Any
ECG abnormality variable indicated the presence of at least one
of the following ECG risk markers: QRS duration ≥ 110 ms,
QTc ≥ 450 ms in men, or ≥470 ms in women, presence of
ECG signs of LVH, T-wave inversion, inferolateral ER or fQRS.
Prevalence and risks for endpoints of any other ECG abnormality
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was not assessed in this study. Subjects with a bundle branch
block were excluded from the final study population.
Follow-Up and Endpoints
In the Coronary Heart Disease Study of the Finnish Mobile
Clinic Health Examination Survey, baseline measurements
were performed 1966-1972. The participants were followed for
30 ± 11 years until the end of year 2007. In the Mini-Finland
Study the baseline measurements were performed 1978–1980 and
participants were followed for 24.0± 10.6 years from the baseline
examinations until the end of 2011. The baseline measurements
of the Health 2000 Study were carried out in 2000 and 2001. The
mean follow-up time was 8.8± 1.1 years until the end of January
2009. In the present analyses the follow-up time was limited to
8 years in all analyses to clarify the role of electrocardiography
in the risk assessment since the cardiovascular risk profile could
ultimately change during a longer follow-up period.
The primary endpoint of the study was cardiac death and
the secondary endpoints were sudden cardiac death and death
from any cause. The causes of death were determined using
nationwide health registers; Causes of Death Register maintained
by Statistics Finland. The quality and validity of these registers has
been well established (Rapola et al., 1997). Death of cardiac cause
was defined using International Classification of Disease code of
cause of death representing the codes I20–I25 in the International
Classification of Diseases 10. A committee of qualified and
experienced cardiologists unaware of the ECG analysis reviewed
all the cardiac deaths. They evaluated each case by using the death
certificates and hospital records. Definition used for SCD is based
on definitions presented in Cardiac Arrhythmia Pilot Study and
has been described earlier in detail (Greene et al., 1989; Tikkanen
et al., 2009). In addition, death was classified as SCD if the event
was unwitnessed yet lacking the evidence of other cause of death.
All three studies were approved by the local ethics committees
and followed the guidelines of The Declaration of Helsinki.
Statistical Analyses
All continuous variables are presented as mean ± standard
deviation (SD) and categorical variables as number of cases
with prevalence among the study population in brackets. When
comparing the categorial variables between groups of interest the
Pearson Chi-Square test was used. Similarly, Student’s t-test was
used when comparing continuous variables. Cox proportional
hazards model was used to calculate hazard ratios (HR) and
their 95% confidence intervals (CI) in the pooled data. In
multivariable analysis, variables were adjusted by age, smoking,
diabetes, CAD, BMI, cholesterol, systolic blood pressure, heart
rate, and the population sample. The statistical significance of
the interaction effect between gender and prognostic value of
each ECG variable was tested using the Cox regression analysis.
In addition, Cox regression was applied separately for each
cohort and the subsequent results were analyzed via random
effects meta-analysis model in order to get the pooled hazard
ratios and heterogeneity analyses (Cochrane’s Q). For Cochranes
Q, P < 0.1 was considered to represent statistically significant
heterogeneity between populations. All statistical analyses were
performed using Statistical Package for Social Studies version
26.0 (IBM SPSS Statistics) and R version 3.6.3 (R Foundation for
Statistical Computing, Vienna, Austria.). We considered p-value
of < 0.05 as statistically significant.
RESULTS
The standard 12-lead ECG markers were analyzed from
20,310 subjects (49.9% women, mean age 44.8 ± 8.7 years).
Characteristics of the study population are represented in
Table 1. On average women were slightly older at the time
of baseline measurements in comparison to men, and they
also had higher heart rate and longer QTc duration than men.
Men had longer QRS complexes than women. There were
considerably more smokers among men than in women in each
study population combined, and men also had on average higher
prevalence of diabetes mellitus. Prevalence for each end point
were considerably higher among male subjects in comparison
to female subjects. Approximately two fifth of the subjects who
experienced cardiac death (40.6%, N = 317, p < 0.001) or SCD
(40.0%, N = 120, p < 0.001) had CAD. The proportion of CAD
was expectedly higher among male victims: 44.7 vs. 33.2% for
men and women, (respectively) among subjects with cardiac
death (p < 0.001), and 43.8 vs. 28.4% among victims of SCD
(p < 0.001).
During the follow-up of 7.7 ± 1.2 years, a total of 296 cardiac
deaths occurred of which 13.9% were among female subjects
(N = 41, p < 0.001). The prevalence of different ECG markers is
represented in Table 2. At least one ECG abnormality was present
in 61.0% of the female victims of cardiac death. Only prevalence
of fQRS was higher among women than in men, though the
number of cases was so low that no statistically significant
differences in the prevalence of ECG abnormalities between
genders were detected. LVH with and without repolarization
abnormalities, QTc prolongation > 470 ms and inferior or lateral
T-wave inversions associated with the relative risk for cardiac
death among women in univariate model but did not remain
statistically significant after adjustments with age, smoking,
diabetes, CAD, BMI, cholesterol, systolic blood pressure, heart
rate, and the study sample (Table 2). Only extremely prolonged
QTc time associated with higher risk for cardiac death among
women than in men, but this ECG marker was found only
from one woman. In random effects meta-analysis any of the
ECG abnormalities were not statistically significant in women.
However, statistically significant interaction effect was observed
between gender and prognostic value of LVH (Table 3), and
it provided stronger prognostic value for cardiac death in
women than in men.
Among male subjects who had died for cardiac causes at least
one ECG abnormality was present in 72.5%. The prevalence of
each ECG variable, excluding fQRS, was slightly higher among
male cardiac death victims in comparison to female cardiac death
victims. Among men prolonged QRS duration, LVH with strain
changes, inferior or lateral T-wave inversions and inferolateral
ER predicted the occurrence of cardiac death in multivariate
model (Table 2). In random effects meta-analysis prolonged QRS
[HR: 3.0 (95% CI: 1.7–5.2, P < 0.001), Cochrane Q-value: 1.1
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TABLE 1 | The baseline characteristics of each population sample.
Finnish mobile clinic health

















Continuous variables Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Age (years) 44.3 ± 8.4 43.7 ± 8.5 44.9 ± 9.3 44.4 ± 9.1 45.4 ± 8.5 45.6 ± 8.4
BMI (kg/m2) 26.2 ± 4.4 25.6 ± 3.3 25.5 ± 4.5 25.8 ± 3.5 26.1 ± 5.0 27.0 ± 4.2
Systolic blood pressure
(mmHg)
138.1 ± 23.5 138.7 ± 19.5 137.9 ± 20.9 139.8 ± 18.2 125.9 ± 18.4 131.6 ± 16.6
Cholesterol (mmol/l) 6.5 ± 1.3 6.5 ± 1.3 3.9 ± 1.1 4.5 ± 1.3 5.7 ± 1.1 6.0 ± 1.1
QRS duration (ms) 84.8 ± 7.0 88.4 ± 7.8 82.6 ± 7.8 89.4 ± 8.8 86.5 ± 8.4 95.5 ± 10.1
QTc (ms) 415.2 ± 26.2 401.7 ± 27.1 419.5 ± 23.7 405.3 ± 23.8 416.9 ± 15.9 410.9 ± 15.6
Heart rate (1/min) 79.6 ± 15.5 72.0 ± 14.2 69.0 ± 12.7 64.7 ± 12.8 63.8 ± 10.3 62.3 ± 11.1
Categorial variables N (%) N (%) N (%) N (%) N (%) N (%)
QRS ≥ 110 ms 7 (0.1%) 59 (1.0%) 6 (0.2%) 42 (1.7%) 13 (0.6%) 166 (8.0%)
QTc ≥ 470 ms
(W)/ ≥ 450 ms (M)
107 (2.1%) 232 (4.1%) 51 (1.9%) 75 (3.1%) 17 (0.7%) 31 (1.5%)
QTc ≥ 490 ms 16 (0.3%) 14 (0.2%) 14 (0.5%) 5 (0.2%) 2 (0.1%) 1 (0.0%)
LVH 1,058 (20.5%) 2,465 (43.8%) 139 (5.2%) 467 (19.0%) 76 (3.3%) 275 (13.2%)
LVH + T-wave inversion 6 (0.1%) 26 (0.5%) 8 (0.3%) 20 (0.8%) 3 (0.1%) 2 (0.1%)
Inferior or lateral T-wave
inversion
29 (0.6%) 45 (0.8%) 31 (1.2%) 36 (1.5%) 6 (0.3%) 7 (0.3%)
Inferolateral ER 224 (4.3%) 406 (7.2%) 361 (13.4%) 472 (19.2%) 35 (1.5%) 130 (6.3%)
Lateral ER 111 (2.2%) 151 (2.8%) 194 (7.2%) 183 (7.4%) 28 (1.2%) 101 (4.9%)





175 (3.4%) 225 (4.1%) 238 (8.9%) 295 (12.0%) 22 (1.0%) 56 (2.7%)
Any fQRS 778 (15.2%) 1,196 (21.4%) 465 (17.3%) 418 (17.0%) 1,324 (58.2%) 1,392 (68.6%)
Lateral fQRS 30 (0.7%) 52 (1.2%) 48 (1.8%) 48 (2.0%) 818 (36.0%) 1,050 (51.7%)
Inferior fQRS 650 (13.0%) 1,062 (19.5%) 375 (14.0%) 327 (13.3%) 701 (30.8%) 592 (29.2%)
Anterior fQRS 141 (3.1%) 173 (3.8%) 65 (2.4%) 68 (2.8%) 163 (7.2%) 146 (7.2%)
Smoking 680 (13.2%) 2,990 (53.0%) 431 (16.0%) 964 (39.2%) 502 (22.1%) 653 (31.5%)
Diabetes 82 (1.6%) 111 (2.0%) 58 (2.2%) 90 (3.7%) 54 (2.4%) 103 (5.0%)
CAD 753 (14.6%) 714 (12.7%) 110 (4.1%) 156 (6.3%) 13 (0.6%) 56 (2.7%)
Cardiac death 22 (0.4%) 154 (2.7%) 12 (0.4%) 73 (3.0%) 7 (0.3%) 28 (1.3%)
Sudden cardiac death 12 (0.2%) 73 (1.3%) 6 (0.2%) 26 (1.1%) 4 (0.2%) 28 (1.4%)
All-cause mortality 115 (2.2%) 408 (7.2%) 63 (2.3%) 174 (7.1%) 38 (1.7%) 85 (4.1%)
For categorical variables values are presented as number of cases within genders and corresponding percentage within brackets. Continuous values are presented as
mean with standard deviation (SD) below to it. Underlined values differed statistically significantly (p < 0.05) between genders. BMI, body mass index; CAD, coronary
artery disease; SD, standard deviation.
(P = 0.582)] and inferior or lateral T-wave inversion [HR: 3.8
(95% CI: 2.0–7.0, P < 0.001), Cochrane Q-value: 2.5 (P = 0.293)]
remained statistically significant in competing risks regression
multivariable model and associated with cardiac death, as well
as any ECG abnormality [HR: 1.6 (95% CI: 1.0–2.4, P = 0.035),
Cochrane Q-value: 3.0 (P = 0.229)].
The prognostic value of ECG variables for SCD and all-cause
mortality are shown in Tables 4, 5. T-wave inversions, extremely
prolonged QTc and LVH remained statistically significant
predictors for SCD in multivariable analysis both in women and
in men. In men, T-wave inversion [HR: 3.2 (95% CI: 1.7–6.1,
P = 0.001), Cochrane Q-value: 1.9 (P = 0.386)] and LVH [HR:
1.6 (95% CI: 1.1–2.4, P = 0.025), Cochrane Q-value: 0.158
(P = 0.924)] remained statistically significant risk factors for SCD
also in random effect meta-analysis as did any ECG abnormality
[HR: 1.7 (95% CI: 1.1–2.7, P = 0.011), Cochrane Q-value: 0.630
(P = 0.730)] and prolonged QRS duration [HR: 3.4 (95% CI:
1.8–6.4, P < 0.001), Cochrane Q-value: 1.1 (P = 0.573)]. Any
of the ECG variables were not statistically significant among
women in random effect meta-analysis, and no statistically
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TABLE 2 | The gender differences in the prevalence and risks for cardiac death of each ECG risk marker with 8 years follow-up time.
Women, N = 41 Men, N = 255
Unadjusted Adjusted Unadjusted Adjusted
N (%) HR (95% CI) P-value HR (95% CI) P-value N (%) HR (95% CI) P-value HR (95% CI) P-value
Any ECG
abnormality
25 (61.0%) 2.2 (1.2–4.2) 0.012 1.6 (0.80–3.1) 0.185 182 (72.5%) 1.7 (1.3–2.2) <0.001 1.6 (1.2–2.1) 0.002
QRS ≥ 110 ms 0 (0.0%) No events No events 14 (5.5%) 2.2 (1.3–3.8) 0.004 3.1 (1.8–5.3) <0.001
QTc ≥ 470 ms
(W)/ ≥ 450 ms (M)
3 (7.3%) 4.6 (1.4–14.9) 0.011 3.2 (0.95–10.9) 0.061 23 (9.2%) 3.1 (2.0–4.7) <0.001 1.3 (0.80–2.0) 0.306
QTc ≥ 490 ms 1 (2.4%) 8.0 (1.1–58.1) 0.040 9.4 (1.2–71.7) 0.031 1 (0.4%) 2.5 (0.35–17.9) 0.357 1.4 (0.19–10.2) 0.737
LVH 13 (31.7%) 3.3 (1.7–6.3) <0.001 1.8 (0.79–3.9) 0.167 97 (38.2%) 1.4 (1.1–1.7) <0.019 1.2 (0.90–1.6) 0.209
LVH + T-wave
inversion
2 (4.9%) 38.5 (9.3–159.4) <0.001 3.2 (0.40–25.3) 0.275 13 (5.1%) 17.0 (9.7–29.8) <0.001 3.4 (1.9–6.2) <0.001
Inferior or lateral
T-wave inversion
3 (7.3%) 12.9 (4.0–41.7) <0.001 2.0 (0.47–8.8) 0.341 26 (10.2%) 17.8 (11.8–26.7) <0.001 4.3 (2.8–6.7) <0.001
Inferolateral ER 2 (4.9%) 0.79 (0.19–3.3) 0.748 0.64 (0.15–2.7) 0.542 31 (12.2%) 1.3 (0.87–1.8) 0.218 1.1 (0.78–1.7) 0.438
Lateral ER 1 (2.4%) 0.74 (0.10–5.4) 0.766 0.54 (0.07–4.1) 0.553 11 (4.4%) 1.0 (0.55–1.8) 0.978 1.0 (0.56–1.9) 0.904





2 (4.9%) 1.2 (0.28–4.8) 0.847 1.6 (0.38–6.9) 0.511 19 (7.6%) 1.4 (0.86–2.2) 0.192 1.7 (1.0–2.7) 0.033
Any fQRS 14 (34.1%) 1.5 (0.80–2.9) 0.197 1.6 (0.78–3.3) 0.197 77 (31.0%) 1.1 (0.81–1.4) 0.685 1.3 (0.97–1.7) 0.079
Lateral fQRS 6 (16.2%) 1.8 (0.77–4.4) 0.171 2.4 (0.64–9.3) 0.188 25 (11.5%) 0.88 (0.56–1.3) 0.537 1.7 (0.99–3.0) 0.054
Inferior fQRS 8 (20.0%) 1.2 (0.55–2.6) 0.641 1.1 (0.49–2.6) 0.777 50 (20.8%) 1.1 (0.77–1.4) 0.725 1.2 (0.86–1.62) 0.300
Anterior fQRS 3 (8.3%) 2.2 (0.69–7.3) 0.181 2.3 (0.69–7.7) 0.175 13 (6.0%) 1.4 (0.82–2.5) 0.195 1.3 (0.70–2.2) 0.464
CI, confidence interval; ER, early repolarization; fQRS, fragmented QRS; HR, hazard ratio; LVH, left ventricular hypertrophy. Results are adjusted by age, smoking, diabetes,
CAD, BMI, cholesterol, systolic blood pressure, heart rate, and the study sample. Statistically significant values p < 0.05 are written in bold.
TABLE 3 | The interaction effect between sex and the prognostic value of each ECG variable.
Women vs. Men
Cardiac death SCD All-cause mortality
HR 95% CI P-value HR 95% CI P-value HR 95% CI P-value
Any ECG abnormality 1.3 0.67–2.6 0.419 1.4 0.51–3.7 0.532 1.7 1.2–2.3 0.001
QRS ≥ 110 ms No events in women No events in women 1.2 0.16–8.8 0.868
QTc ≥ 470 ms (W)/ ≥ 450 ms
(M)
1.5 0.43–5.2 0.530 2.0 0.42–9.8 0.384 0.91 0.44–1.9 0.914
QTc ≥ 490 ms 0.32 0.02–5.2 0.420 0.33 0.02–5.4 0.437 1.9 0.39–9.7 0.420
Inferior or lateral T-wave
inversion
0.72 0.21–2.5 0.600 0.92 0.19–4.4 0.913 0.81 0.40–1.7 0.561
LVH 2.4 1.2–4.9 0.014 2.5 0.99–6.4 0.053 1.7 1.2–2.4 0.003
LVH + T-wave inversion 2.2 0.48–10.1 0.311 1.6 0.20–13.8 0.649 2.3 0.95–5.4 0.064
Inferolateral ER 0.63 0.14–2.7 0.531 0.85 0.10–6.9 0.877 1.6 0.98–2.6 0.059
Lateral ER 0.73 0.09–5.8 0.768 No events 3.1 1.6–5.7 <0.001
Inferior ER 1.1 0.13–8.9 0.938 0.93 0.09–9.2 0.949 0.73 0.31–1.7 0.482
Inferolateral ER + horizontal/
descending ST-segment
0.84 0.19–3.8 0.821 1.3 0.15–11.2 0.824 1.2 0.65–2.2 0.548
Any fQRS 1.4 0.72–2.9 0.301 1.0 0.40–2.8 0.923 1.6 1.1–2.2 0.009
Lateral fQRS 2.1 0.79–5.5 0.133 0.71 0.97–2.6 0.064 1.8 1.1–3.0 0.014
Inferior fQRS 1.1 0.49–2.6 0.764 1.1 0.33–3.4 0.919 0.82 no events 0.986
Anterior fQRS 1.5 0.42–5.7 0.514 0.97 0.11–8.6 0.980 1.8 0.35–1.9 0.647
Interactions between gender and ECG risk markers were assessed using Cox regression analysis.
CI , confidence interval; ER, early repolarization; fQRS, fragmented QRS; HR, hazard ratio; LVH, left ventricular hypertrophy; SCD, sudden cardiac death. HR, hazard ratio.
Statistically significant values (p < 0.05) are written in bold.
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TABLE 4 | The gender differences in the prevalence and risks for sudden cardiac death of each ECG risk marker with 8 years follow-up time.
Women, N = 22 Men, N = 127
Unadjusted Adjusted Unadjusted Adjusted
N (%) HR (95% CI) P-value HR (95%CI) P-value N (%) HR (95% CI) P-value HR (95% CI) P-value
Any ECG
abnormality
15 (68.2%) 3.1 (1.3–7.5) 0.014 2.3 (0.90–5.8) 0.084 98 (77.8%) 2.2 (1.5–3.4) <0.001 1.9 (1.3–2.9) 0.003
QRS ≥ 110 ms 0 (0.0%) No events No events 11 (8.7%) 3.6 (1.9–6.7) <0.001 3.7 (1.9–7.0) <0.001
QTc ≥ 470 ms
(W)/ ≥ 450 ms (M)
2 (9.1%) 5.8 (1.4–24.9) 0.018 4.2 (0.93–19.0) 0.063 11 (8.7%) 2.9 (1.5–5.3) 0.001 1.3 (0.67–2.5) 0.437
QTc ≥ 490 ms 1 (4.5%) 15.2 (2.0–113.2) 0.008 14.8 (1.8–119.1) 0.011 1 (0.8%) 4.9 (0.69–35.3) 0.112 2.4 (1.0–5.4) 0.039
Inferior or lateral
T-wave inversion
2 (9.1%) 16.3 (3.8–69.8) <0.001 5.4 (1.1–25.6) 0.033 13 (10.2%) 17.5 (9.9–31.1) <0.001 4.6 (2.5–8.5) <0.001
LVH 8 (36.4%) 4.0 (1.7–9.6) 0.002 2.8 (1.0–7.8) 0.047 53 (42.1%) 1.6 (1.1–2.3) 0.010 1.7 (1.2–2.6) 0.008
LVH + T-wave
inversion
1 (4.5%) 36.1 (4.8–268.3) <0.001 8.0 (0.88–71.9) 0.064 8 (6.3%) 21.0 (10.3–43.1) <0.001 5.3 (2.4–11.4) <0.001
Inferolateral ER 1 (4.5%) 0.74 (0.10–5.5) 0.765 0.61 (0.08–4.8) 0.639 11 (8.7%) 0.87 (0.47–1.6) 0.651 0.90 (0.48–1.7) 0.732
Lateral ER 0 (0.0%) No events No events 1 (0.8%) 0.18 (0.03–1.3) 0.084 0.20 (0.03–1.4) 0.104





1 (4.5%) 1.1 (0.14–7.9) 0.949 1.5 (0.20–11.4) 0.699 6 (4.8%) 0.83 (0.37–1.9) 0.663 1.1 (0.48–2.5) 0.819
Any fQRS 7 (31.8%) 1.4 (0.56–3.4) 0.485 1.4 (0.52–3.7) 0.504 43 (35.8%) 1.3 (0.90–1.9) 0.154 1.3 (0.84–1.9) 0.270
Lateral fQRS 2 (10.5%) 1.1 (0.26–4.8) 0.880 0.98 (0.16–6.1) 0.986 20 (19.0%) 1.6 (0.97–2.6) 0.064 1.7 (0.86–3.3) 0.127
Inferior fQRS 4 (18.2%) 1.1 (0.36–3.2) 0.904 1.1 (0.36–3.2) 0.906 23 (20.0%) 1.0 (0.64–1.6) 0.984 1.0 (0.66–1.6) 0.866
Anterior fQRS 1 (5.3%) 1.4 (0.18–10.3) 0.760 1.3 (0.16–9.7) 0.828 6 (5.9%) 1.4 (0.62–3.2) 0.417 1.1 (0.48–2.5) 0.815
CI, confidence interval; ER, early repolarization; fQRS, fragmented QRS; HR, hazard ratio; LVH, left ventricular hypertrophy. Results are adjusted by age, smoking, diabetes,
CAD, BMI, cholesterol, systolic blood pressure, heart rate, and the study sample. Statistically significant values (p < 0.05) are written in bold.
significant interaction between gender and the ECG variables
were seen for SCD. LVH, prolonged QRS duration and any
ECG abnormality associated with moderately higher risk of
SCD among subjects with prior CAD. LVH with repolarization
abnormalities and T wave inversions associated with considerably
higher risk among SCD victims without prior CAD but number
of cases was substantially low. Differences among SCD victims
with and without prior CAD are represented in Table 6. For
all-cause mortality statistically significant interactions between
gender and LVH, lateral ER, total and lateral fQRS as well as
any ECG abnormality were seen, the abnormalities having greater
prognostic value in women than in men.
DISCUSSION
In the current study, the gender differences in the prevalence
and prognostic value of different ECG markers were studied in
a large middle-aged general population, and many differences
between men and women were found. The prevalence of all
endpoints was considerably higher in men than in women.
Women had more often a normal electrocardiogram compared
to men. Electrocardiographic LVH seemed to have different
prognostic value between middle-aged men and women.
The prevalence of all endpoints in the current study were
considerably higher among men which is in line with the previous
reports (Kannel et al., 1998; Albert et al., 2003; Haukilahti
et al., 2019). The risk of CAD increases considerably with age
among both genders (Jousilahti et al., 1999). Approximately
40% of the subjects with cardiac death or SCD had CAD, and
the relatively low proportion of CAD can be largely explained
with the mean age of the study population. The proportion of
CAD was expectedly higher among male subjects with cardiac
endpoint. Both CAD (Airaksinen et al., 2016) and SCD (Kannel
et al., 1998) have been shown to occur approximately 10 years
later in women than in men. However, the prevalence of CVD
among women has been reported to equal that of men with
advancing age (Maffei et al., 2019). In addition, the prevalence
of any vascular disease has been shown to be higher with each
decade of life, and each additional decade of life approximately
doubles the risk of vascular disease (Savji et al., 2013).
The presence of any ECG abnormality was significantly more
commonly found among male subjects who had experienced
cardiac death in comparison to their female counterparts. Two
fifths of the female cardiac death victims did not have any
prior ECG abnormalities while approximately a quarter of the
male victims had a normal electrocardiogram. The difference in
the proportion of normal electrocardiograms narrowed in SCD
victims, yet the gender difference still existed.
In the present study, ECG signs of LVH was found to be more
prevalent among men who had experienced cardiac death, yet the
overall number of subjects with ECG sign of LVH was low in both
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TABLE 5 | The gender differences in the prevalence and risks for all-cause mortality of each ECG risk marker with 8 years follow-up time.
Women, N = 216 Men, N = 667
Unadjusted Adjusted Unadjusted Adjusted
N (%) HR (95% CI) P-value HR (95% CI) P-value N (%) HR (95% CI) P-value HR (95% CI) P-value
Any ECG
abnormality
131 (60.9%) 2.2 (1.7–2.9) <0.001 1.8 (1.4–2.4) <0.001 445 (67.5%) 1.3 (1.1–1.6) 0.001 1.2 (1.0–1.5) 0.012
QRS ≥ 110 ms 1 (0.5%) 1.8 (0.26–13.0) 0.548 1.7 (0.24–12.1) 0.601 26 (3.9%) 1.5 (1.0–2.3) 0.032 1.9 (1.3–2.8) 0.002
QTc ≥ 470 ms
(W)/ ≥ 450 ms (M)
9 (4.2%) 2.5 (1.3–4.9) 0.006 1.6 (0.81–3.1) 0.182 55 (8.4%) 2.8 (2.1–3.6) <0.001 1.3 (0.96–1.7) 0.090
QTc ≥ 490 ms 2 (0.9%) 3.0 (0.74–12.0) 0.123 1.7 (0.42–7.1) 0.444 6 (0.9%) 5.8 (2.6–12.9) <0.001 2.4 (1.0–5.4) 0.039
Inferior or lateral
T-wave inversion
10 (4.6%) 7.9 (4.2–14.9) <0.001 2.7 (1.4–5.5) 0.005 39 (5.8%) 9.7 (7.0–13.4) <0.001 3.1 (2.2–4.4) <0.001
LVH 50 (23.1%) 4.0 (1.7–9.6) 0.002 1.5 (1.0–2.1) 0.032 239 (36.0%) 1.6 (1.1–2.3) 0.010 1.1 (0.91–1.3) 0.369
LVH + T-wave
inversion
7 (3.2%) 24.9 (11.7–52.8) <0.001 7.4 (3.1–17.3) <0.001 22 (3.3%) 10.8 (7.1–16.5) <0.001 3.0 (1.9–4.8) <0.001
Inferolateral ER 23 (10.6%) 1.8 (1.2–2.8) 0.006 1.5 (0.98–2.4) 0.062 74 (11.1%) 1.1 (0.90–1.5) 0.283 1.1 (0.84–1.4) 0.543
Lateral ER 18 (8.3%) 2.7 (1.7–4.4) <0.001 2.1 (1.3–3.5) 0.003 25 (3.9%) 0.88 (0.59–1.3) 0.521 0.92 (0.61–1.4) 0.673





14 (6.5%) 1.6 (0.90–2.7) 0.111 1.8 (1.0–3.1) 0.039 47 (7.2%) 1.3 (0.96–1.7) 0.098 1.5 (1.1–2.1) 0.007
Any fQRS 71 (27.5%) 1.5 (1.1–1.9) 0.010 1.5 (1.1–2.1) 0.007 187 (28.5%) 0.94 (0.79–1.1) 0.448 1.1 (0.91–1.3) 0.374
Lateral fQRS 27 (14.2%) 1.6 (1.0–2.4) 0.029 2.0 (1.1–3.4) 0.017 66 (11.3%) 0.86 (0.67–1.1) 0.256 1.5 (1.1–2.1) 0.025
Inferior fQRS 50 (23.5%) 1.5 (1.1–2.0) 0.016 1.5 (1.1–2.1) 0.018 127 (19.7%) 0.99 (0.81–1.2) 0.897 1.1 (0.87–1.3) 0.582
Anterior fQRS 7 (3.7%) 0.94 (0.44–2.0) 0.866 0.94 (0.44–2.0) 0.881 28 (4.8%) 1.1 (0.78–1.7) 0.494 1.1 (0.72–1.6) 0.763
CI, confidence interval; ER, early repolarization; fQRS, fragmented QRS; HR, hazard ratio; LVH, left ventricular hypertrophy. Statistically significant values (p < 0.05) are
written in bold. Results are adjusted by age, smoking, diabetes, CAD, BMI, cholesterol, systolic blood pressure, heart rate, and the study sample.
genders leading to lack of statistical power in the multivariate
model. However, in the gender interaction analysis the prognostic
value of LVH for cardiac death and all-cause mortality was
stronger in women than in men. The risk of cardiovascular events
among asymptomatic subjects is 1.6-fold in subjects with LVH,
and slightly higher among women than in men (Chou et al.,
2011). Previously, LVH has also been associated with the risk
of cardiovascular mortality (Prineas et al., 2001). In a study by
Desai et al. (2012), the risk of cardiovascular mortality was over
eightfold among women without clinical CVD but the presence
of ECG sign of LVH defined by criteria of Sokolow-Lyon, and
nearly fivefold in men. In addition, the risk of adverse outcomes
was found to be higher in each subgroup and among both genders
if LVH co-existed with repolarization abnormalities. Previously,
in a large middle aged general population cohort the ECG sign of
LVH observed with strain pattern was associated with over sixfold
risk for CAD event in white men and over twofold risk in black
women (Machado et al., 2006). In a current study the general
population sample was even larger than in those two studies
with similar kind of findings. In the present study LVH with
inferolateral T wave inversion associated with increased relative
risk for cardiac death in men, yet the number of cases was limited.
Previously, T-wave inversions and changes in ST segment with
ECH LVH are associated with more severe LVH and elevated risk
of adverse outcomes (Hancock et al., 2009; Rautaharju et al., 2009;
Bang et al., 2014).
Prolonged QRS duration is a well-known marker of adverse
prognosis in subjects with cardiac disease (Kashani and Barold,
2005; Schinkel et al., 2009) but also in the general population
(Aro et al., 2011). However, the previous literature on sex
differences in prognostic value of QRS prolongation is sparse.
In the current study, prolonged QRS duration was more
prevalent among male subjects who experienced cardiac death
and it was associated with higher relative risk for cardiac
death among men than among women. Other known risk
factors for cardiovascular events are changes in ST segment
and T-wave (Chou et al., 2011). In the current study we
did not assess ST segment changes alone. T-wave inversions
were slightly more commonly found among women than in
men who had experienced cardiac death, yet they remained
statistically significant in a multivariate model for this endpoint
only among men. Previously T-wave abnormalities have been
associated with 1.6–2.1 -fold risk for CAD in the general
population (Machado et al., 2006; Chou et al., 2011) and
inferolateral T-wave inversions also to increased risk for cardiac
death and SCD (Aro et al., 2012; Laukkanen et al., 2014).
However, the information of gender differences in prognostic
value of T wave inversions is sparse. In a current study, T-wave
inversions and LVH remained significant predictors of SCD in
multivariable analysis also in women. No gender interaction
was seen in any of the variables as predictors of SCD. These
data show that ECG may be even better independent predictor
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TABLE 6 | Differences in the prevalence and risks for sudden cardiac death among subjects with and without previous coronary artery disease.
SCD victims without prior CAD, N = 93 SCD victims with prior CAD, N = 56
Unadjusted Adjusted Unadjusted Adjusted
N (%) HR (95% CI) P-value HR (95%CI) P-value N (%) HR (95% CI) P-value HR (95% CI) P-value
Any ECG
abnormality
66 (71.7%) 2.5 (1.6–3.9) <0.001 1.9 (1.2–3.0) 0.009 47 (83.9%) 4.0 (2.0–8.2) <0.001 3.6 (1.7–7.4) 0.001
QRS ≥ 110 ms 6 (6.5%) 5.0 (2.2–11.3) <0.001 3.7 (1.6–8.7) 0.002 5 (8.9%) 5.5 (2.2–13.9) <0.001 7.5 (2.8–19.7) <0.001
QTc ≥ 470 ms
(W)/ ≥ 450 ms (M)
6 (6.5%) 3.1 (1.4–7.2) 0.007 1.7 (0.71–4.0) 0.233 7 (12.5%) 2.4 (1.1–5.3) 0.031 2.0 (0.88–4.7) 0.098
QTc ≥ 490 ms 1 (1.1%) 5.0 (0.69–35.7) 0.111 3.0 (0.40–21.9) 0.286 1 (1.8%) 4.0 (0.56–29.1) 0.168 4.0 (0.51–32.1) 0.188
Inferior or lateral
T-wave inversion
7 (7.5%) 27.5 (12.7–59.4) <0.001 15.8 (6.8–36.7) <0.001 8 (14.3%) 3.7 (1.7–7.8) 0.001 2.8 (1.3–6.1) 0.009
LVH 32 (34.4%) 2.0 (1.3–3.1) 0.002 1.9 (1.2–3.1) 0.009 29 (52.7%) 2.3 (1.4–3.9) 0.002 2.7 (1.5–4.8) 0.001
LVH + T-wave
inversion
2 (2.2%) 25.0 (6.1–101.4) <0.001 9.3 (2.1–41.1) 0.003 7 (12.7%) 8.0 (3.6–17.7) <0.001 6.1 (2.5–14.6) <0.001
Inferolateral ER 6 (6.5%) 0.81 (0.35–1.8) 0.615 0.82 (0.35–1.9) 0.644 6 (10.7%) 1.2 (0.53–2.9) 0.623 1.2 (0.49–2.7) 0.748
Lateral ER 1 (1.1%) 0.28 (0.04–2.0) 0.201 0.29 (0.04–2.1) 0.224 0 (0.0%) No events No events





4 (4.3%) 0.88 (0.32–2.4) 0.793 1.3 (0.47–3.5) 0.629 3 (5.4%) 1.0 (0.33–3.3) 0.940 1.1 (0.34–3.5) 0.897
Any fQRS 33 (36.7%) 1.5 (0.97–2.3) 0.072 1.2 (0.74–2.0) 0.437 17 (32.7%) 1.8 (0.99–3.2) 0.053 1.5 (0.82–2.7) 0.195
Lateral fQRS 17 (20.2%) 1.9 (1.1–3.3) 0.017 1.5 (0.71–3.0) 0.307 5 (12.5%) 2.9 (1.1–7.5) 0.025 2.7 (0.96–7.8) 0.059
Inferior fQRS 15 (16.9%) 0.88 (0.50–1.5) 0.645 0.83 (0.48–1.5) 0.523 12 (25.0%) 1.7 (0.90–3.3) 0.101 1.6 (0.81–3.0) 0.190
Anterior fQRS 5 (6.0%) 1.5 (0.62–3.8) 0.349 1.3 (0.53–3.3) 0.541 2 (5.3%) 1.1 (0.26–4.4) 0.930 0.77 (0.18–3.2) 0.716
CAD, coronary artery disease; CI, confidence interval; ER, early repolarization; fQRS, fragmented QRS; HR, hazard ratio; LVH, left ventricular hypertrophy. Results are
adjusted by age, smoking, diabetes, CAD, BMI, cholesterol, systolic blood pressure, heart rate, medication for hypertension and the study sample. Statistically significant
values (p < 0.05) are written in bold.
of more specific modes of death, such as SCD, in women.
Cardiac death can be due to many different mechanisms, which
may explain why it is not well predicted by standard ECG,
especially in women.
We pooled the data from three different population samples,
because the event rates in single samples are relatively low
in women. This is an obvious limitation of the study. The
study populations represent the Finnish general population
from different decades and treatments for cardiac diseases have
developed dramatically during the follow-up period. On this
account all results might not be completely transferable to
current decade even though a quarter of the population was
studied in the twenty-first century. It is also possible that the
health behavior has changed considerably during the decades.
However, the populations were quite homogenous in terms of
cardiovascular risk factors. The lack of other ethnicities may
also be considered as a limitation of our study. Regarding the
ECG variables determined in this study, standard QTc limits
for men and women were used (Rautaharju et al., 2009), but
there is no uniformly accepted gender-specific limits for QRS
duration, even though there is a subtle difference in QRS duration
between men and women. Therefore, QRS > 110 ms was used
as a cut-off point in the study and the selected cut off point in
the study and the selected cut off point was based on one large
retrospective register study (Desai et al., 2006). In addition, LVH
could have been more definitely diagnosed by echocardiography,
which was not available at the start of the collection of these
populations. However, recently ECG LVH has supposed to be
at least partly distinct entity from echocardiographic LVH (Aro
and Chugh, 2016) and also to be independently prognostic for
cardiovascular mortality and morbidity with similar level as LVH
diagnosed by magnetic resonance imaging (Bacharova et al.,
2015). To our knowledge, this is the largest study which has
been conducted to determine the prevalence and prognostic
significance of multiple ECG variants for cardiac mortality, SCD
and all-cause mortality in the middle-aged general population.
Still, the event rate in SCD, especially among women, remains
low due to the nature of SCD which causes challenges in
obtaining enough statistical power when performing gender
stratified analysis.
In conclusion, we studied the impact of gender on the
prevalence and prognostic value of different ECG markers
in a large middle-aged general population. All mortality
endpoints were more commonly found among male subjects.
The prevalence of all ECG variables apart from fQRS was
higher among men in comparison to women. Based on
this study, electrocardiographic LVH has a slightly different
prognostic value between middle-aged men and women, with
more pronounced prognostic value for cardiac death among
women. Similarly, T-wave inversions, prolonged QRS duration
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and inferolateral ER were associated with increased risk of cardiac
death only among men.
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